CG Oncology, Inc.
CGON
$20.64
$0.422.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 295.37% | 165.38% | 294.83% | 30.80% | |
| Total Receivables | 748.91% | 13,600.00% | -- | -69.64% | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 79.79% | 88.54% | -- | 85.69% | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 288.52% | 163.26% | -- | 31.87% | |
|
|
|||||
| Total Current Assets | 288.52% | 163.26% | -- | 31.87% | |
| Net Property, Plant & Equipment | 0.41% | -38.55% | -- | -2.96% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -97.99% | -96.74% | -- | 14,100.00% | |
| Total Assets | 278.72% | 160.74% | -- | 34.89% | |
|
|
|||||
| Total Accounts Payable | 101.02% | 107.85% | -- | 229.14% | |
| Total Accrued Expenses | 47.01% | 31.30% | -- | 89.19% | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -14.29% | 4.65% | -- | -97.63% | |
| Total Finance Division Other Current Liabilities | -60.93% | -79.29% | -- | 545.09% | |
| Total Other Current Liabilities | -60.93% | -79.29% | -- | 545.09% | |
| Total Current Liabilities | 49.91% | 33.56% | -- | -7.62% | |
|
|
|||||
| Total Current Liabilities | 49.91% | 33.56% | -- | -7.62% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -78.69% | -76.49% | -- | -5.06% | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -96.31% | |
| Total Liabilities | 47.61% | 30.65% | -- | -35.71% | |
|
|
|||||
| Common Stock & APIC | 13,804.68% | 12,358.26% | -- | 87.86% | |
| Retained Earnings | -67.75% | -63.57% | -- | -59.76% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 695.76% | 596.90% | 832.29% | -58.44% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | 51.77% | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 51.77% | |
|
|
|||||
| Total Common Equity | 695.76% | 596.90% | 832.29% | -58.44% | |
| Total Preferred Equity | -- | -- | -- | 51.77% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 296.87% | 168.56% | 354.51% | 47.62% | |
|
|
|||||